Coordinator: | ||
Institution: |
- TP1 Identification and characterisation of tumor relevant genes for acute myeloid leukemia (AML)
- TP 2 - Identifikation neuer molekularer Veränderungen bei Patienten mit akuter myeloischer Leukämie und normalem Karyotyp
- TP4 Impact of activating NOTCH1 mutations on the pathogenesis of childhood precursor T-cell lymphoblastic leukemia (T-ALL)
- TP5 MLL Translocations: Fusion Proteins and Stem Cell Program
- TP6 Identification of genomic, epigenomic and proteomic targets of the CALM/AF10 fusion protein
- TP7 The significance of dysregulated MEIS1 homeobox gene expression in the pathogenesis of acute myeloid leukemia (AML)
- TP8 WNT, stem cell functions and acute myeloid leucemia
- TP9 The genetic basis of sensitivity to Abl kinase inhibitors in Ph+ALL
- TP10 Molecular inhibitors of the oncogenic property of AML1/ETO
- TP 11 Vitamin A Resistence in acute myeloid leukemia
- TP 12 Early diagnosis and molecular-based treatment of very highly resistant acute lymphoblastic leukemia in childhood
- TP13 Molecular dissection, functional evaluation and preclinical targeting of intermediate-risk childhood acute lymphoblastic leukemia
- TP 15 NGFN Leukemia Bioinformatics Resource
- Publications
KTT
MEDIA
CURRENT
NGFN-MEETING-2012
NGFN- MEETING
NGFN1&2
LINKS